BTK antibody
Principal name
BTK antibody
Alternative names for BTK antibody
Bruton tyrosine kinase, AGMX1, ATK, BPK, Tyrosine-protein kinase BTK, Agammaglobulinaemia tyrosine kinase, B-cell progenitor kinase
Ncbi ID
9606, NP_000052.1, NP_000052, NM_000061, Q06187, NP_038510.2
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P), Immunocytochemistry/Immunofluorescence (ICC/IF), Immunoprecipitation (IP), Flow Cytometry (F), Luminex (LMNX), Frozen Sections (C)
Background of BTK antibody
Brutons tyrosine kinase (BTK) is a member of the BTK/Tec family of cytoplasmic tyrosine kinases. Like other BTK family members, it contains a pleckstrin homology (PH) domain, Src homology SH3 and SH2 domains. BTK plays an important role in B cell development. Activation of B cells by various ligands is accompanied by BTK membrane translocation mediated by its PH domain binding to phosphatidylinositol-3,4,5-trisphosphate. The membrane located BTK is active and associated with transient phosphorylation of two tyrosine residues, Tyr551 and Tyr223. Tyr551 in the activation loop is transphosphorylated by the Src family tyrosine kinase, leading to autophosphorylation at Tyr223 within the SH3 domain, which is necessary for full activation. The activation of BTK is negatively regulated by PKC beta through phosphorylation of BTK at Ser180, which results in reduced membrane recruitment, transphosphorylation and subsequent activation. The PKC/BTK inhibitory signal is likely to be a key determinant of the B cell receptor signaling threshold to maintain optimal BTK activity.
Formalin-fixed and paraffin-embedded human cancer tissue reacted with BTK polyclonal antibody ( Cat # PAB3419 ) , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry ; clinical relevance has not been evaluated. BC = breast carcinoma.
Western blot analysis of BTK polyclonal antibody ( Cat # PAB3419 ) transiently transfected HEK293 cell line lysate ( 1 µg/lane ) . BTK polyclonal antibody ( arrow ) was detected using the purified polyclonal antibody ( 1 : 1500 dilution ) .
The BTK polyclonal antibody ( Cat # PAB3419 ) is used in Western blot to detect BTK in Ramos cell lysate.
Immunoblot analysis of cell lysates. Lane 1 : U937 cell lysate. Lane 2 : Raji cell lysate. Lane 3 : HL-60 cell lysate.
Figure 1. Western blot analysis using anti-BTK Pab (Cat#AP14458PU-N) to detect BTK in Ramos cell lysate.
Figure 2. (TOP) Western blot analysis of anti-BTK Pab (Cat#AP14458PU-N) transiently transfected HEK-293 cell line lysate (1ug/lane). BTK pab(arrow) was detected using the purified Pab (1:1500 dilution). (BOTTOM) Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by DAB staining.
Immunocytochemistry of BTK in Daudi cells with BTK polyclonal antibody ( Cat # PAB12936 ) at 10 µg/ml.
Western blot analysis of BTK in U-937 cell lysate with BTK polyclonal antibody ( Cat # PAB12936 ) at ( A ) 0.5, ( B ) 1, and ( C ) 2 µg/ml.
Immunohistochemistry analyzes of BTK antibody (AP20276PU-N) in paraffin-embedded human breast carcinoma tissue.
Western blot analysis of BTK antibody (AP20276PU-N) in extracts from HeLa cells.
Human Spleen: Formalin-Fixed, Paraffin-Embedded (FFPE)
Human Tonsil: Formalin-Fixed, Paraffin-Embedded (FFPE)
Sample (30 ug of whole cell lysate). A: Raji. 7.5% SDS PAGE. BTK antibody diluted at 1/5000.
Immunohistochemical analysis of paraffin-embedded human lymph-node tissues (left) and human lymph follicle tissues (right), showing cytoplasmic and membrane localization using BTK antibody Cat.-No AM06170SU-N with DAB staining.
Immunofluorescence analysis of Jurkat cells using BTK antibody Cat.-No AM06170SU-N
Western blot analysis using BTK antibody Cat.-No AM06170SU-N against K562 (Lane 1), MCF-7 (Lane 2), Jurkat (Lane 3) and HEK293 (Lane 4) cell lysate.
Western blot analysis of extracts from Hela cells treated with serum using BTK (phospho-Tyr223) Antibody AP55690PU-N.The lane on the right is treated with the antigen-specific peptide.
Western blot analysis of BTK (pY223) expression in DLD (A); mouse liver (B); rat liver (C); rat kidney (D) whole cell lysates.
Immunofluorescent analysis of BTK (pY551) staining in Jurkat cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue).
Western blot analysis of BTK (pY551) expression in Jurkat (A); K562 (B) whole cell lysates.
Immunohistochemical staining of paraffin-embedded Carcinoma of liver tissue using anti-BTK mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA501090, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded Kidney tissue within the normal limits using anti-BTK mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA501090, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded liver tissue within the normal limits using anti-BTK mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA501090, Dilution 1:50)
Anti-BTK mouse monoclonal antibody (TA501090) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY BTK(RC211582).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BTK (RC211582, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BTK.
HEK293T cells transfected with either pCMV6-ENTRY BTK(RC211582)(Red) or empty vector control plasmid(Blue) were immunostained with anti-BTK mouse monoclonal(TA501090), and then analyzed by flow cytometry.
Immunohistochemical staining of paraffin-embedded liver tissue within the normal limits using anti-BTK mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA501091, Dilution 1:50)
Anti-BTK mouse monoclonal antibody (TA501091) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY BTK(RC211582).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BTK (RC211582, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BTK.
HEK293T cells transfected with either pCMV6-ENTRY BTK(RC211582)(Red) or empty vector control plasmid(Blue) were immunostained with anti-BTK mouse monoclonal(TA501091), and then analyzed by flow cytometry.
Flow cytometric Analysis of Jurkat cells, using anti-BTK antibody(TA501091),(Red), compared to a nonspecific negative control antibody,(Blue).
Immunohistochemical staining of paraffin-embedded Carcinoma of liver tissue using anti-BTK mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA501092, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded Kidney tissue within the normal limits using anti-BTK mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA501092, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded liver tissue within the normal limits using anti-BTK mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA501092, Dilution 1:50)
Anti-BTK mouse monoclonal antibody (TA501092) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY BTK(RC211582).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BTK (RC211582, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BTK.
HEK293T cells transfected with either pCMV6-ENTRY BTK(RC211582)(Red) or empty vector control plasmid(Blue) were immunostained with anti-BTK mouse monoclonal(TA501092), and then analyzed by flow cytometry.
Immunohistochemical staining of paraffin-embedded Carcinoma of prostate tissue using anti-BTK mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA501093, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of ovary tissue using anti-BTK mouse monoclonal antibody. (TA501092, Dilution 1:50; heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min)
Anti-BTK mouse monoclonal antibody (TA501093) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY BTK(RC211582).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BTK (RC211582, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BTK.
HEK293T cells transfected with either pCMV6-ENTRY BTK(RC211582)(Red) or empty vector control plasmid(Blue) were immunostained with anti-BTK mouse monoclonal(TA501093), and then analyzed by flow cytometry.
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of ovary tissue using anti-BTK mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA501094, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded Kidney tissue within the normal limits using anti-BTK mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA501094, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of colon tissue using anti-BTK mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA501094, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded Carcinoma of liver tissue using anti-BTK mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA501094, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded prostate tissue within the normal limits using anti-BTK mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA501094, Dilution 1:50)
Immunofluorescent staining of A549 cells using anti-BTK mouse monoclonal antibody (TA501094).
Immunofluorescent staining of HT29 cells using anti-BTK mouse monoclonal antibody (TA501094).
Anti-BTK mouse monoclonal antibody (TA501094) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY BTK(RC211582).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BTK (RC211582, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BTK.
HEK293T cells transfected with either pCMV6-ENTRY BTK(RC211582)(Red) or empty vector control plasmid(Blue) were immunostained with anti-BTK mouse monoclonal(TA501094), and then analyzed by flow cytometry.
Immunohistochemical staining of paraffin-embedded Kidney tissue within the normal limits using anti-BTK mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA501100, Dilution 1:50)
Anti-BTK mouse monoclonal antibody (TA501100) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY BTK(RC211582).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BTK (RC211582, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BTK.
HEK293T cells transfected with either pCMV6-ENTRY BTK(RC211582)(Red) or empty vector control plasmid(Blue) were immunostained with anti-BTK mouse monoclonal(TA501100), and then analyzed by flow cytometry.
Immunohistochemical staining of paraffin-embedded Carcinoma of liver tissue using anti-BTK mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA501101, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded Kidney tissue within the normal limits using anti-BTK mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA501101, Dilution 1:50)
Anti-BTK mouse monoclonal antibody (TA501101) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY BTK(RC211582).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BTK (RC211582, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BTK.
HEK293T cells transfected with either pCMV6-ENTRY BTK(RC211582)(Red) or empty vector control plasmid(Blue) were immunostained with anti-BTK mouse monoclonal(TA501101), and then analyzed by flow cytometry.
Anti-BTK mouse monoclonal antibody (TA501102) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY BTK(RC211582).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BTK (RC211582, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BTK.
HEK293T cells transfected with either pCMV6-ENTRY BTK(RC211582)(Red) or empty vector control plasmid(Blue) were immunostained with anti-BTK mouse monoclonal(TA501102), and then analyzed by flow cytometry.
Immunohistochemical staining of paraffin-embedded Human liver tissue within the normal limits using anti-BTK mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA501118, Dilution 1:50)
Immunofluorescent staining of HT29 cells using anti-BTK mouse monoclonal antibody (TA501118).
Anti-BTK mouse monoclonal antibody (TA501118) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY BTK(RC211582).
Western blot analysis of extracts (10ug) from 3 different cell lines by using anti-BTK monoclonal antibody at 1:200 dilution.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BTK (RC211582, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BTK.
Flow cytometry analysis of monocytes from non-XLA or XLA patients using anti-BTK antibody (TA501118). Image courtesy: Dr. H. Kanaegane, University of Toyama, Japan.
Immunohistochemical staining of paraffin-embedded Carcinoma of liver tissue using anti-BTK mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA501119, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded Kidney tissue within the normal limits using anti-BTK mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA501119, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded colon tissue within the normal limits using anti-BTK mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA501119, Dilution 1:50)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of ovary tissue using anti-BTK mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 100C for 10min, TA501119, Dilution 1:50)
Anti-BTK mouse monoclonal antibody (TA501119) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY BTK(RC211582).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BTK (RC211582, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-BTK.
HEK293T cells transfected with either pCMV6-ENTRY BTK(RC211582)(Red) or empty vector control plasmid(Blue) were immunostained with anti-BTK mouse monoclonal(TA501119), and then analyzed by flow cytometry.
BTK Luminex with 1H7 Capture (TA600509) and 12D4 Detection (TA700509) Antibodies. Substrate used: Recombinant Human BTK (TP311582)
BTK Luminex with 6H9 Capture (TA600510) and 12D4 Detection (TA700509) Antibodies. Substrate used: Recombinant Human BTK (TP311582)
BTK Luminex with 6H9 Capture (TA600510) and 13E5 Detection (TA700510) Antibodies. Substrate used: Recombinant Human BTK (TP311582)
BTK Luminex with 10E10 Capture (TA600511) and 6H9 Detection (TA700511) Antibodies. Substrate used: Recombinant Human BTK (TP311582)
BTK Luminex with 10E10 Capture (TA600511) and 12H4 Detection (TA700512) Antibodies. Substrate used: Recombinant Human BTK (TP311582)
BTK Luminex with 12D4 Capture (TA600512) and 10E10 Detection (TA700513) Antibodies. Substrate used: Recombinant Human BTK (TP311582)
BTK Luminex with 13E5 Capture (TA600513) and 6H9 Detection (TA700511) Antibodies. Substrate used: Recombinant Human BTK (TP311582)
BTK Luminex with 1H7 Capture (TA600509) and 12D4 Detection (TA700509) Antibodies. Substrate used: Recombinant Human BTK (TP311582)
BTK Luminex with 6H9 Capture (TA600510) and 12D4 Detection (TA700509) Antibodies. Substrate used: Recombinant Human BTK (TP311582)
BTK Luminex with 6H9 Capture (TA600510) and 13E5 Detection (TA700510) Antibodies. Substrate used: Recombinant Human BTK (TP311582)
BTK Luminex with 10E10 Capture (TA600511) and 6H9 Detection (TA700511) Antibodies. Substrate used: Recombinant Human BTK (TP311582)
BTK Luminex with 13E5 Capture (TA600513) and 6H9 Detection (TA700511) Antibodies. Substrate used: Recombinant Human BTK (TP311582)
BTK Luminex with 10E10 Capture (TA600511) and 12H4 Detection (TA700512) Antibodies. Substrate used: Recombinant Human BTK (TP311582)
BTK Luminex with 12D4 Capture (TA600512) and 10E10 Detection (TA700513) Antibodies. Substrate used: Recombinant Human BTK (TP311582)
Western blot analysis of BTK in U937 cell lysate with BTK antibody at (A) 0.5, (B) 1, and (C) 2 ug/mL.
Immunocytochemistry of BTK in Daudi cells with BTK antibody at 10 ug/mL.
Immunofluorescence of BTK in Daudi cells with BTK antibody at 10 ug/mL.
Western Blot: BTK Antibody - WB analysis of BTKpY223 with peptide competition: 1. ab only, 2. 200 molar excess unmodified immunizing peptide and 3. 200 molar excess modified immunizing peptide.
Immunohistochemistry: BTK Antibody - IHC analysis of BTK in kidney cancer xenograft using DAB with hematoxylin counterstain.
Western blot analysis of extracts from Hela cells, using BTK (Ab-222) antibody (#TA313379, Line 1 and 2).The lane on the right is treated with the synthesized peptide.
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using BTK (Ab-222) antibody (#TA313379).The picture on the right is treated with the synthesized peptide.
Western blot analysis of extracts of Daudi cell lines, using BTK antibody.
Immunohistochemistry of paraffin-embedded rat lung using BTK antibody at dilution of 1:100 (400x lens).
Immunohistochemistry of paraffin-embedded rat brain using BTK antibody at dilution of 1:100 (400x lens).
Western Blot: BTK Antibody (7F12H4) [TA336560] - Analysis of BTK expression in 1) truncated BTK recombinant protein and 2) K562 cell lysate.
Western Blot: BTK Antibody (7F12H4) [TA336560] - Analysis of BTK expression in 2) Raji, 3) A431 whole cell lysates and 4) human tonsil tissue extract.
Immunohistochemistry-Paraffin: BTK Antibody (7F12H4) [TA336560] - Immunohistochemical analysis of paraffin-embedded human lymph-node tissues (left) and human lymph follicle tissues (right), showing cytoplasmic and membrane localization using BTK mouse mAb
Immunocytochemistry/Immunofluorescence: BTK Antibody (7F12H4) [TA336560] - The BTK antibody was tested in A431 cells against DyLight 488 (Green). Actin and nuclei were counterstained for Phalloidin (Red) and DAPI (Blue), respectively.
Western blot detection of BTK in Daudi,Jurkat(BTK negative),K562,Ramos and Raji cell lysates using BTK mouse mAb (1:1000 diluted).Predicted band size:77KDa.Observed band size:77KDa.
Western blot analysis on HeLa cell lysate using Phospho-BTK(Tyr223) Antibody
- Quick-Filters:
- Cited (1)
- Highly Validated (10)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA501118 | BTK antibody |
||||||
| anti-BTK mouse monoclonal antibody, clone OTI10E10 (formerly 10E10) | |||||||
 |
Mouse | IgG2a | OTI10E10 | Purified | Hu | F, ICC/IF, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
 +5 additional images |
Top Selling product! Published recently! Highly validated antibody!
|
||||||
| TA336560 | BTK antibody |
||||||
| Mouse Monoclonal BTK Antibody (7F12H4) | |||||||
![Western Blot: BTK Antibody (7F12H4) [TA336560] - Analysis of BTK expression in 1) truncated BTK recombinant protein and 2) K562 cell lysate.](https://m1.acris-antibodies.com/catalog/product/cache/1/small_image/50x50/9df78eab33525d08d6e5fb8d27136e95/OriGene/NB110-87047-1-W.jpg) |
Mouse | IgG1 | 7F12H4 | Purified | Hu, Prim | C, E, ICC/IF, P, WB |
0.1 ml /
€395.00
|
| OriGene Technologies, Inc. | |||||||
| +3 additional images |
Highly validated antibody! |
||||||
| TA501090 | BTK antibody |
||||||
| anti-BTK mouse monoclonal antibody, clone OTI12D4 (formerly 12D4) | |||||||
 |
Mouse | IgG2a | OTI12D4 | Purified | Hu | F, ICC/IF, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +5 additional images |
Highly validated antibody!
|
||||||
| TA501091 | BTK antibody |
||||||
| anti-BTK mouse monoclonal antibody, clone OTI12H4 (formerly 12H4) | |||||||
 |
Mouse | IgG3 | OTI12H4 | Purified | Hu | F, ICC/IF, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +4 additional images |
Highly validated antibody!
|
||||||
| TA501092 | BTK antibody |
||||||
| anti-BTK mouse monoclonal antibody, clone OTI3D11 (formerly 3D11) | |||||||
 |
Mouse | IgG3 | OTI3D11 | Purified | Hu | F, ICC/IF, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +5 additional images |
Highly validated antibody!
|
||||||
| TA501093 | BTK antibody |
||||||
| anti-BTK mouse monoclonal antibody, clone OTI6H9 (formerly 6H9) | |||||||
 |
Mouse | IgG2b | OTI6H9 | Purified | Hu | F, ICC/IF, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +4 additional images |
Highly validated antibody!
|
||||||
| TA501094 | BTK antibody |
||||||
| anti-BTK mouse monoclonal antibody, clone OTI3A2 (formerly 3A2) | |||||||
 |
Mouse | IgG1 | OTI3A2 | Purified | Hu | F, ICC/IF, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +9 additional images |
Highly validated antibody!
|
||||||
| TA501100 | BTK antibody |
||||||
| anti-BTK mouse monoclonal antibody, clone OTI3E9 (formerly 3E9) | |||||||
 |
Mouse | IgG1 | OTI3E9 | Purified | Hu | F, ICC/IF, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +3 additional images |
Highly validated antibody!
|
||||||
| TA501101 | BTK antibody |
||||||
| anti-BTK mouse monoclonal antibody, clone OTI1H7 (formerly 1H7) | |||||||
 |
Mouse | IgG1 | OTI1H7 | Purified | Hu | F, ICC/IF, P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +4 additional images |
Highly validated antibody!
|
||||||
| TA501119 | BTK antibody |
||||||
| anti-BTK mouse monoclonal antibody, clone OTI15G8 (formerly 15G8) | |||||||
 |
Mouse | IgG1 | OTI15G8 | Purified | Hu | F, ICC/IF, P, WB |
0.1 ml /
€379.00
|
| OriGene Technologies, Inc. | |||||||
| +6 additional images |
Highly validated antibody!
|
||||||
| TA306188 | BTK (N-term) antibody |
||||||
| Rabbit Polyclonal BTK Antibody | |||||||
 |
Rabbit | IgG | Aff - Purified | Hu, Ms | E, ICC/IF, P, WB |
0.1 mg /
€415.00
|
|
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|||||||
| TA309594 | BTK antibody |
||||||
| Rabbit Polyclonal BTK [p Tyr223] Antibody | |||||||
 |
Rabbit | Purified | Hu, Ms | C, ICC/IF, WB |
0.1 ml /
€590.00
|
||
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA313379 | BTK antibody |
||||||
| Rabbit polyclonal BTK (Ab-222) antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms | E, P, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA327086 | BTK antibody |
||||||
| BTK Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt |
0.1 mg /
€335.00
|
||
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|||||||
| TA346898 | BTK antibody |
||||||
| Mouse Monoclonal BTK Antibody | |||||||
 |
Mouse | IgG1 | 5B12-C9-F10 | Purified | WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA348449 | BTK antibody |
||||||
| Rabbit Polyclonal Anti-Phospho-BTK(Tyr223) Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | WB |
0.1 mg /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA501102 | BTK antibody |
||||||
| anti-BTK mouse monoclonal antibody, clone OTI13E5 (formerly 13E5) | |||||||
 |
Mouse | IgG2a | OTI13E5 | Purified | Hu | F, ICC/IF, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|
||||||
| TA600509 | BTK antibody |
||||||
| Luminex validated purified BTK mouse monoclonal antibody (clone 1H7, clone OTI1H7 (formerly 1H7) | |||||||
 |
Mouse | IgG1 | OTI1H7 | Purified | Hu | LMNX |
0.1 mg /
€350.00
|
| OriGene Technologies, Inc. | |||||||
| TA600510 | BTK antibody |
||||||
| Luminex validated purified BTK mouse monoclonal antibody (clone 6H9, clone OTI6H9 (formerly 6H9) | |||||||
 |
Mouse | IgG1 | OTI6H9 | Purified | Hu | LMNX |
0.1 mg /
€350.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA600511 | BTK antibody |
||||||
| Luminex validated purified BTK mouse monoclonal antibody (clone 10E, clone OTI10E10 (formerly 10E10) | |||||||
 |
Mouse | IgG1 | OTI10E10 | Purified | Hu | LMNX |
0.1 mg /
€350.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
